Research Methodology – Gene Therapy Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Gene Therapy Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Gene Therapy Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share
- Prevalence and incidence rate of diseases that can be treated with gene therapy
- Patent status of various gene therapies
- Government regulations and policies related to gene therapy
- Current advancements and development in gene therapy
- Geographic regions where gene therapies are being actively adopted
- Market participants and competition
- Investments and funding in gene therapy research
- Healthcare infrastructure and accessibility
- Clinical trial pipeline for gene therapies
- Insurance coverage and reimbursement policies for gene therapy
Key Market Indicators
- Number of approved gene therapies
- Number of ongoing clinical trials for gene therapies
- Total healthcare expenditure in gene therapy
- Research & development activities in the gene therapy space
- Investments in the gene therapy sector
- Market size and growth rate
- Geographical distribution of market share
- Technological advancements in gene therapy
- Market trends and future prospects
Growth Trends
- Increasing alliances and collaborations between gene therapy companies
- Emergence of gene editing technologies like CRISPR
- Rise in the number of gene therapy clinical trials
- The advent of personalized gene therapy
- Growing applications of gene therapy in rare diseases and cancers
- Increasing acceptance and adoption of gene therapy treatments
- Government initiatives promoting gene therapy research
- Increased funding for gene therapy research and development
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Gene Therapy Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Gene Therapy Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
